Given an anion gap of 21 mEq/L, a bicarbonate of 19 mEq/L, and a ketone level of 1.56 mmol/L, does this indicate diabetic ketoacidosis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Does This Patient Have DKA?

This patient likely has mild DKA and should be treated accordingly, despite the borderline bicarbonate level. The combination of elevated anion gap (21 mEq/L), low-normal bicarbonate (19 mEq/L), and elevated ketones (1.56 mmol/L) meets diagnostic criteria for mild diabetic ketoacidosis, though you must obtain a pH to confirm the diagnosis 1.

Diagnostic Assessment

What the Numbers Tell You

The patient's laboratory values fall into a diagnostic gray zone that requires careful interpretation:

  • Anion gap of 21 mEq/L: Elevated (normal ≤12 mEq/L), indicating metabolic acidosis 1
  • Bicarbonate of 19 mEq/L: Just above the traditional DKA threshold of <18 mEq/L, but still abnormally low 1
  • Ketones of 1.56 mmol/L: Elevated and clinically significant (β-hydroxybutyrate >1.5 mmol/L indicates ketoacidosis) 2

Critical Missing Information

You must obtain a venous or arterial pH immediately to definitively diagnose DKA. According to established criteria, mild DKA is defined as 1:

  • Blood glucose >250 mg/dL
  • pH 7.25-7.30
  • Bicarbonate 15-18 mEq/L
  • Positive ketones

However, your patient's bicarbonate of 19 mEq/L sits just above this threshold, creating diagnostic ambiguity.

Why This Likely Represents DKA

The Anion Gap and Ketone Elevation Are Key

The elevated anion gap (21 mEq/L) combined with ketones of 1.56 mmol/L strongly suggests ongoing ketoacid production 2. A β-hydroxybutyrate level ≥1.5 mmol/L has 98% sensitivity for DKA 2. The bicarbonate of 19 mEq/L, while technically above the traditional cutoff, is still abnormally low and consistent with metabolic acidosis.

Beware of Mixed Acid-Base Disorders

Critical pitfall: This patient may have a concurrent metabolic alkalosis masking more severe DKA 3, 4. Recent evidence shows that 23% of DKA cases present with pH >7.4 (diabetic ketoalkalosis) due to mixed acid-base disorders, yet still require full DKA treatment 4. Common causes include:

  • Vomiting (causing metabolic alkalosis)
  • Diuretic use
  • Nasogastric suction

If this patient has been vomiting or has other causes of alkalosis, the "true" acidosis may be more severe than the bicarbonate suggests 3, 4.

The Diagnostic Algorithm

  1. Obtain pH immediately (venous is acceptable; typically 0.03 units lower than arterial) 1
  2. If pH ≤7.30: Definite DKA—start treatment
  3. If pH 7.30-7.40: Likely mild DKA or mixed disorder—start treatment
  4. If pH >7.40: Consider diabetic ketoalkalosis with mixed disorder—still requires DKA treatment if ketones elevated and anion gap present 4

Treatment Recommendation

Treat this patient as mild DKA regardless of the final pH, given the elevated ketones and anion gap 1. The 2004 Diabetes Care guidelines specifically state that patients with mild DKA can be treated with subcutaneous insulin rather than continuous IV infusion 1:

  • Initial dose: 0.4-0.6 units/kg body weight (half IV bolus, half subcutaneous)
  • Maintenance: 0.1 unit/kg subcutaneous regular insulin every hour
  • Fluid resuscitation: 15-20 mL/kg/h isotonic saline initially 1
  • Monitor: Glucose, electrolytes, and ketones every 2-4 hours

When to Use IV Insulin Instead

Switch to continuous IV insulin infusion (0.1 units/kg/h) if 5, 1:

  • pH <7.25 (moderate-to-severe DKA)
  • Patient cannot tolerate subcutaneous administration
  • Inadequate response to subcutaneous therapy

Resolution Criteria

DKA is resolved when 1:

  • Glucose <200 mg/dL
  • Bicarbonate ≥18 mEq/L
  • pH >7.3

Note that your patient's current bicarbonate of 19 mEq/L already meets resolution criteria, but the elevated ketones and anion gap indicate ongoing ketoacid production requiring treatment.

Key Clinical Pearls

  • β-hydroxybutyrate is the preferred ketone measurement over urine ketones, as it directly measures the predominant ketoacid 1
  • Ketones clear more slowly than glucose—don't stop treatment based on glucose normalization alone 1
  • Check for precipitating factors: infection, medication non-compliance, new-onset diabetes, SGLT2 inhibitor use 6, 7
  • Monitor potassium closely: hypokalaemia occurs in ~50% during treatment and severe hypokalaemia (<2.5 mEq/L) increases mortality 5

References

1
Guideline

hyperglycemic crises in diabetes.

Diabetes Care, 2004

2
Research

Point-of-care test identifies diabetic ketoacidosis at triage.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

5
Guideline

management of diabetes and hyperglycaemia in the hospital.

The Lancet Diabetes and Endocrinology, 2021

6
Research

Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.

The American journal of emergency medicine, 2021

Related Questions

Is diabetic ketoacidosis present in a patient with severe hyperglycemia, normal serum bicarbonate, and a mildly elevated anion gap?
In a 46-year-old male with acute abdomen, hyperglycemia (blood glucose 436 mg/dL), positive ketones, normal vital signs, serum sodium 139 mmol/L, and serum potassium 3 mmol/L, what is the next step in management?
Should a 52-year-old woman with type 2 diabetes who was admitted for diabetic ketoacidosis, now has a closed anion gap, and is on metformin 850 mg twice daily plus basal insulin glargine 10 units daily, have her metformin dose increased, continue the current insulin regimen, or add a thiazolidinedione?
A 71-year-old female with type 2 diabetes mellitus, weight 74 kg, normal creatinine, moderately reduced estimated glomerular filtration rate, elevated anion gap, low bicarbonate, severe hyperglycemia, elevated serum ketones, mild acidosis, high serum osmolality, history of pancreatitis, currently taking glipizide only, and hemoglobin A1c rising from 6.8% to 13.1%—what is the appropriate management?
Is it appropriate to give the patient oral intake while she remains on an insulin infusion, given that her anion gap is now 14 (within normal range)?
What is bremelanotide, its recommended dosing, contraindications, and side effects for treating acquired hypoactive sexual desire disorder in premenopausal women?
What are the indications, dosing regimen, contraindications, adverse effects, and counseling considerations for flibanserin in premenopausal women with acquired generalized hypoactive sexual desire disorder?
What are the optimal nutrition and supplement recommendations for weight loss in a generally healthy menopausal woman?
Does sevoflurane cause uterine smooth muscle relaxation?
What 5‑HT2A antagonists are appropriate for a premenopausal woman with acquired generalized hypoactive sexual desire disorder, and what are their dosing and safety considerations?
Can diabetic ketoacidosis (DKA) be diagnosed when β‑hydroxybutyrate (BHB) is only about 1.5 mmol/L, given an elevated anion gap and low bicarbonate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.